⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26504 | 0.80 | — | — | |
| SCHEMBL478050 | 0.77 | — | — | |
| SCHEMBL1031731 | 0.72 | — | — | |
| SCHEMBL3317384 | 0.72 | — | — | |
| SCHEMBL477683 | 0.65 | — | — | |
| SCHEMBL17871005 | 0.61 | — | — | |
| SCHEMBL22959 | 0.61 | — | — | |
| SCHEMBL775492 | 0.60 | — | — | |
| SCHEMBL2538374 | 0.59 | — | — | |
| SCHEMBL15352148 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014016789-A1 | PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE DERIVATIVES AS PDE9 INHIBITORS | CELON PHARMA S.A. (PL) | 2014-01-30 | — | — | WO | claimed |
| WO-2024070789-A1 | ADHESIVE AND ADHESIVE SHEET | 日東電工株式会社 | 2024-04-04 | — | — | WO | disclosed |
| CN-116891690-A | Pressure-sensitive adhesive optical film and laminate | 日东电工株式会社 | 2023-10-17 | — | — | CN | disclosed |
| CN-116896919-A | Light emitting device | 日东电工株式会社 | 2023-10-17 | — | — | CN | disclosed |
| CN-115362233-A | Interlayer sheet, interlayer sheet with release liner, and optical laminate | 日东电工株式会社 | 2022-11-18 | — | — | CN | disclosed |
| CN-115335479-A | Adhesive and use thereof | 日东电工株式会社 | 2022-11-11 | — | — | CN | disclosed |
| CN-115335634-A | Light emitting device | 日东电工株式会社 | 2022-11-11 | — | — | CN | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-20210384554-A1 | LITHIUM SECONDARY BATTERY ELECTROLYTE FOR REDUCING INTERNAL RESISTANCE OF BATTERY AND LITHIUM SECONDARY BATTERY | GUANGZHOU TINCI MATERIALS TECHNOLOGY CO., LTD. (CN) | 2021-12-09 | — | — | US | disclosed |
| EP-3819976-A1 | LITHIUM SECONDARY BATTERY ELECTROLYTE FOR REDUCING INTERNAL RESISTANCE OF BATTERY AND LITHIUM SECONDARY BATTERY | Guangzhou Tinci Materials Technology Co., Ltd (CN) | 2021-05-12 | — | — | EP | disclosed |
| US-6316437-B1 | ADRENERGIC RECEPTOR ANTAGONISTS | MERCK & CO., INC. | 2001-11-13 | — | — | US | disclosed |
| US-6235759-B1 | BENIGN PROSTATIC HYPERPLASIA; HYPOTENSIVE AGENTS | MERCK & CO., INC. | 2001-05-22 | — | — | US | disclosed |
| US-6232318-B1 | COMPOUNDS SUCH AS 1-BENZYL-3-(3-(4-(4-FLUOROPHENYL)PIPERIDIN -1-YL)PROPYL)-5-METHYL-1H-PYRIMIDINE-2,4-DIONE; PROVIDES RELIEF TO MALES SUFFERING FROM BENIGN PROSTATIC HYPERPLASIA | MERCK & CO., LTD. | 2001-05-15 | — | — | US | disclosed |
| US-6228870-B1 | BENIGN PROSTATIC HYPERPLASIA; REDUCTION OF HYPOTENSION SIDE EFFECT | MERCK & CO., INC. | 2001-05-08 | — | — | US | disclosed |
| WO-2001022919-A2 | SPIRO[BICYCLIC -AZACYCLOALKYL AND -CYCLOALKYL] DERIVATIVES AND USES THEREOF | MERCK & CO., INC. (US) | 2001-04-05 | — | — | WO | disclosed |
| WO-2000043374-A1 | POLYAZANAPHTHALENONE DERIVATIVES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-07-27 | — | — | WO | disclosed |
| WO-2000027827-A1 | OXAZOLIDINONES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000027817-A1 | OXAZOLIDINONES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000027816-A1 | OXAZOLIDINONES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-2000025782-A1 | DIHYDROPYRIDINONES AND PYRROLINONES USEFUL AS ALPHA 1A ADRENOCEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2000-05-11 | — | — | WO | disclosed |